The initial public offer (IPO) of Glenmark Life Sciences was subscribed 2.8 times on Tuesday, the first day of the issue.
The wealthy investor portion was subscribed 88 per cent, and the retail portion was subscribed 5.3 times. On Monday, the company allotted shares worth Rs 454 crore to anchor investors.
The IPO closes on Thursday.
Glenmark Life Sciences, a developer and manufacturer of active pharmaceutical ingredients (APIs), has priced its IPO between Rs 695 and Rs 720 per equity share. At the upper end, the company will have a market cap of Rs 8,822 crore.
Glenmark Life, a wholly-owned